Item 2.02 Results of Operations and Financial Conditions
On August 10, 2018, Adamis Pharmaceuticals Corporation (the "Company") issued a
press release announcing certain financial information for the quarter ended
June 30, 2018. A copy of the press release is furnished as Exhibit 99.1 to this
Current Report on Form 8-K and is incorporated herein by reference.
The information furnished in this Form 8-K and the press release attached as
Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to
the liabilities of that section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933 or the Exchange Act,
whether made before or after the date hereof, regardless of any general
incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits
Exhibit No. Exhibit Description
99.1 Press release dated August 10, 2018
© Edgar Online, source Glimpses